These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 30605630)
1. Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment. Cheng G; Liu J; Gilbert A; Cao Y; An C; Lv Z; Wang C; Nie R; Zhang J; Liu Y; Xia M; Li S; Cai H; Li Y; Li Y; Qin X Clin Chim Acta; 2019 Mar; 490():135-141. PubMed ID: 30605630 [TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy. Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
4. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365 [TBL] [Abstract][Full Text] [Related]
5. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy]. Lin W; Li H; Li X; Qin Y; Su Y; Yu Y; Guan Y; Duan L; Li Y; Wen Y; Li X Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):783-8. PubMed ID: 26674797 [TBL] [Abstract][Full Text] [Related]
6. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522 [TBL] [Abstract][Full Text] [Related]
7. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA. Kaga H; Komatsuda A; Yamamoto S; Kikuchi T; Kamata M; Sato A; Odaka M; Yokota SI; Takahashi N; Wakui H Clin Exp Nephrol; 2019 Apr; 23(4):465-473. PubMed ID: 30756249 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody. Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677 [TBL] [Abstract][Full Text] [Related]
9. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China. Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930 [TBL] [Abstract][Full Text] [Related]
10. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568 [TBL] [Abstract][Full Text] [Related]
11. PLA2R and membranous nephropathy: A 3 year prospective Australian study. Hill PA; McRae JL; Dwyer KM Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693 [TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
13. Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients. Liu Y; Li X; Ma C; Wang P; Liu J; Su H; Zhuo H; Kong X; Xu D; Xu D Clin Chim Acta; 2018 Jan; 476():9-14. PubMed ID: 29126817 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy]. Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696 [TBL] [Abstract][Full Text] [Related]
15. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy. Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283 [TBL] [Abstract][Full Text] [Related]
16. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy. Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
20. A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor. Zhang Q; Liu X; Zhang Z; Wu M; Huang B; Zhang Y; Liu B; Qi Z; Shan W; Wang L; Hu Z; Sun Z Medicine (Baltimore); 2019 Nov; 98(45):e17658. PubMed ID: 31702617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]